The Role of Microglia and the TLR4 Pathway in Neuronal Apoptosis and Vasospasm After Subarachnoid Hemorrhage

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2013 Jul 16

PMID 23849248

Citations 105

Authors

Khalid A Hanafy

Affiliations

Soon will be listed here.

Abstract

Background: Although microglia and the Toll-like receptor (TLR) pathway have long been thought to play a role in the pathogenesis of aneurysmal subarachnoid hemorrhage (aSAH), thus far only correlations have been made. In this study, we attempted to solidify the relationship between microglia and the TLR pathway using depletion and genetic knockouts, respectively.

Methods: Subarachnoid hemorrhage was induced in TLR4-/-, TRIF-/-, MyD88-/- and wild type C57BL/6 mice by injecting 60 μl of autologous blood near the mesencephalon; animals were euthanized 1 to 15 days after SAH for immunohistochemical analysis to detect microglia or apoptotic cells. Lastly, microglial depletion was performed by intracerebroventricular injection of clodronate liposomes.

Results: On post operative day (POD) 7 (early phase SAH), neuronal apoptosis was largely TLR4-MyD88-dependent and microglial-dependent. By POD 15 (late phase SAH), neuronal apoptosis was characterized by TLR4- toll receptor associated activator of interferon (TRIF)-dependence and microglial-independence. Similarly, vasospasm was also characterized by an early and late phase with MyD88 and TRIF dependence, respectively. Lastly, microglia seem to be both necessary and sufficient to cause vasospasm in both the early and late phases of SAH in our model.

Conclusion: Our results suggest that SAH pathology could have different phases. These results could explain why therapies tailored to aSAH patients have failed for the most part. Perhaps a novel strategy utilizing immunotherapies that target Toll like receptor signaling and microglia at different points in the patient's hospital course could improve outcomes.

Citing Articles

Regulatory T Cell- and Natural Killer Cell-Mediated Inflammation, Cerebral Vasospasm, and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage-A Systematic Review and Meta-Analysis Approach.

Pfnur A, Mayer B, Dorfer L, Tumani H, Spitzer D, Huber-Lang M Int J Mol Sci. 2025; 26(3).

PMID: 39941044 PMC: 11818301. DOI: 10.3390/ijms26031276.

Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.

Luzzi S, Kuru Bektasoglu P, Dogruel Y, Gungor A Neurosurg Rev. 2024; 47(1):305.

PMID: 38967704 PMC: 11226492. DOI: 10.1007/s10143-024-02543-5.

Diffuse microglial responses and persistent EEG changes correlate with poor neurological outcome in a model of subarachnoid hemorrhage.

Geraghty J, Butler M, Maharathi B, Tate A, Lung T, Balasubramanian G Sci Rep. 2024; 14(1):13618.

PMID: 38871799 PMC: 11176397. DOI: 10.1038/s41598-024-64631-2.

CDDO, an Anti-Inflammatory and Antioxidant Compound, Attenuates Vasospasm and Neuronal Cell Apoptosis in Rats Subjected to Experimental Subarachnoid Hemorrhage.

Winardi W, Lo Y, Tsai H, Huang Y, Tseng T, Chung C Curr Issues Mol Biol. 2024; 46(5):4688-4700.

PMID: 38785551 PMC: 11119475. DOI: 10.3390/cimb46050283.

All Three Supersystems-Nervous, Vascular, and Immune-Contribute to the Cortical Infarcts After Subarachnoid Hemorrhage.

Dreier J, Joerk A, Uchikawa H, Horst V, Lemale C, Radbruch H Transl Stroke Res. 2024; 16(1):96-118.

PMID: 38689162 PMC: 11772491. DOI: 10.1007/s12975-024-01242-z.

References

Baldwin M, Loch Macdonald R, Huo D, Novakovic R, Novakovia R, Goldenberg F . Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke. 2004; 35(11):2506-11. DOI: 10.1161/01.STR.0000144654.79393.cf. View

Provencio J, Altay T, Smithason S, Moore S, Ransohoff R . Depletion of Ly6G/C(+) cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage. J Neuroimmunol. 2010; 232(1-2):94-100. PMC: 3053416. DOI: 10.1016/j.jneuroim.2010.10.016. View

Hawkes C, McLaurin J . Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A. 2009; 106(4):1261-6. PMC: 2633563. DOI: 10.1073/pnas.0805453106. View

Zhao X, Grotta J, Gonzales N, Aronowski J . Hematoma resolution as a therapeutic target: the role of microglia/macrophages. Stroke. 2008; 40(3 Suppl):S92-4. DOI: 10.1161/STROKEAHA.108.533158. View

Ma C, Yin W, Cai B, Wu J, Wang J, He M . Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin Med J (Engl). 2009; 122(13):1575-81. View

Wu Y, Tang K, Huang R, Zhuang Z, Cheng H, Yin H . Therapeutic potential of peroxisome proliferator-activated receptor γ agonist rosiglitazone in cerebral vasospasm after a rat experimental subarachnoid hemorrhage model. J Neurol Sci. 2011; 305(1-2):85-91. DOI: 10.1016/j.jns.2011.03.006. View

King Jr J . Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am. 1997; 7(4):659-68. View

Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, Moriwaki T . NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation. 2007; 116(24):2830-40. DOI: 10.1161/CIRCULATIONAHA.107.728303. View

Aoki T, Takenaka K, Suzuki S, Kassell N, Sagher O, Lee K . The role of hemolysate in the facilitation of oxyhemoglobin-induced contraction in rabbit basilar arteries. J Neurosurg. 1994; 81(2):261-6. DOI: 10.3171/jns.1994.81.2.0261. View

10.

Moussaud S, Draheim H . A new method to isolate microglia from adult mice and culture them for an extended period of time. J Neurosci Methods. 2010; 187(2):243-53. DOI: 10.1016/j.jneumeth.2010.01.017. View

11.

Barbagallo I, Marrazzo G, Frigiola A, Zappala A, Volti G . Role of carbon monoxide in vascular diseases. Curr Pharm Biotechnol. 2011; 13(6):787-96. DOI: 10.2174/138920112800399086. View

12.

GRAF C, NIBBELINK D . Cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Report on a randomized treatment study. 3. Intracranial surgery. Stroke. 1974; 5(4):557-601. DOI: 10.1161/01.str.5.4.557. View

13.

Bederson J, Connolly Jr E, Batjer H, Dacey R, Dion J, Diringer M . Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009; 40(3):994-1025. DOI: 10.1161/STROKEAHA.108.191395. View

14.

Faustino J, Wang X, Johnson C, Klibanov A, Derugin N, Wendland M . Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci. 2011; 31(36):12992-3001. PMC: 3539822. DOI: 10.1523/JNEUROSCI.2102-11.2011. View

15.

Lin S, Yin Q, Zhong Q, Lv F, Zhou Y, Li J . Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation. 2012; 9:46. PMC: 3344687. DOI: 10.1186/1742-2094-9-46. View

16.

Zhang G, Ghosh S . Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001; 107(1):13-9. PMC: 198554. DOI: 10.1172/JCI11837. View

17.

Vergouwen M, Ilodigwe D, Loch Macdonald R . Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011; 42(4):924-9. DOI: 10.1161/STROKEAHA.110.597914. View

18.

Sasai M, Yamamoto M . Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors. Int Rev Immunol. 2013; 32(2):116-33. DOI: 10.3109/08830185.2013.774391. View

19.

Simard J, Tosun C, Ivanova S, Kurland D, Hong C, Radecki L . Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage. Transl Stroke Res. 2012; 3(Suppl 1):155-65. PMC: 3372778. DOI: 10.1007/s12975-012-0166-9. View

20.

Aid S, Langenbach R, Bosetti F . Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. J Neuroinflammation. 2008; 5:17. PMC: 2409311. DOI: 10.1186/1742-2094-5-17. View